Regulation of adipocyte formation by GLP-1/GLP-1R signaling

Journal of Biological Chemistry

Volumn 287, Issue 9, 2012, Pages 6421-6430

  Challa, Tenagne Delessa ^a   Beaton, Nigel ^a   Arnold, Myrtha ^a   Rudofsky, Gottfried ^b   Langhans, Wolfgang ^a   Wolfrum, Christian ^a  

^a ETH ZURICH   (Switzerland)

^b UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPOCYTES; ADIPOGENESIS; ADIPOSE TISSUE; DOWN-STREAM; GUT PEPTIDES; IN-VITRO; INSULIN SIGNALING; LIPID HOMEOSTASIS; LONG LASTING; METABOLIC DISORDERS; SIGNALING PATHWAYS; TYPE-2 DIABETES;

CELL DEATH; NUTRIENTS; TISSUE;

MOLECULAR WEIGHT;

GLUCAGON LIKE PEPTIDE 1; GLUCAGON LIKE PEPTIDE 1 RECEPTOR; LIRAGLUTIDE; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN KINASE B; PROTEIN KINASE C;

ADIPOCYTE; ADIPOGENESIS; ANIMAL CELL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; DRUG MECHANISM; ENZYME ACTIVATION; HOMEOSTASIS; IN VITRO STUDY; IN VIVO STUDY; LIPID METABOLISM; MALE; METABOLIC REGULATION; MOLECULAR INTERACTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROADIPOCYTE; PROTEIN ANALYSIS; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEIN FUNCTION; RECEPTOR UPREGULATION; SIGNAL TRANSDUCTION;

3T3-L1 CELLS; ADIPOCYTES; ADIPOGENESIS; ANIMALS; CELL DIFFERENTIATION; CELL DIVISION; DIABETES MELLITUS, TYPE 2; GENE KNOCKDOWN TECHNIQUES; GLUCAGON-LIKE PEPTIDE 1; INTESTINES; MALE; MICE; MICE, INBRED C57BL; OBESITY; PROTEIN KINASE C; RECEPTORS, GLUCAGON; SIGNAL TRANSDUCTION;

EID: 84857461922     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M111.310342     Document Type: Article

References (52)

1. Bays, H. E., González-Campoy, J. M., Bray, G. A., Kitabchi, A. E., Bergman, D. A., Schorr, A. B., Rodbard, H. W., and Henry, R. R. (2008) Pathogenic potential of adipose tissue and metabolic consequences of adipocyte hypertrophy and increased visceral adiposity. Expert Rev. Cardiovasc. Ther. 6, 343-368
2. Hausman, D. B., DiGirolamo, M., Bartness, T. J., Hausman, G. J., and Martin, R. J. (2001) The biology of white adipocyte proliferation. Obes. Rev. 2, 239-254 (Pubitemid 33755900)
3. Kahn, B. B., and Flier, J. S. (2000) Obesity and insulin resistance. J. Clin. Invest. 106, 473-481 (Pubitemid 30666380)
4. Kaplan, N. M. (1998) Obesity in hypertension effects on prognosis and treatment. J. Hypertens. Suppl. 16, S35-S37
5. Jo, J., Gavrilova, O., Pack, S., Jou, W., Mullen, S., Sumner, A. E., Cushman, S. W., and Periwal, V. (2009) Hypertrophy and/or hyperplasia: dynamics of adipose tissue growth. PLoS Comput. Biol. 5, e1000324
6. Kadowaki, T., and Yamauchi, T. (2005) Adiponectin and adiponectin receptors. Endocr. Rev. 26, 439-451 (Pubitemid 40686653)
7. Meissburger, B., Stachorski, L., Röder, E., Rudofsky, G., and Wolfrum, C. (2011) Tissue inhibitor of matrix metalloproteinase 1 (TIMP1) controls adipogenesis in obesity in mice and in humans. Diabetologia 54, 1468-1479
8. Wolfrum, C., Shih, D. Q., Kuwajima, S., Norris, A. W., Kahn, C. R., and Stoffel, M. (2003) Role of Foxa-2 in adipocyte metabolism and differentiation. J. Clin. Invest. 112, 345-356 (Pubitemid 38063763)
9. Hoffstedt, J., Arner, E., Wahrenberg, H., Andersson, D. P., Qvisth, V., Löfgren, P., Rydén, M., Thörne, A., Wirén, M., Palmér, M., Thorell, A., Toft, E., and Arner, P. (2010) Regional impact of adipose tissue morphology on the metabolic profile in morbid obesity. Diabetologia 53, 2496-2503
10. Cornelius, P., MacDougald, O. A., and Lane, M. D. (1994) Regulation of adipocyte development. Annu. Rev. Nutr. 14, 99-129 (Pubitemid 24261832)
11. Hwang, C. S., Loftus, T. M., Mandrup, S., and Lane, M. D. (1997) Adipocyte differentiation and leptin expression. Annu. Rev. Cell Dev. Biol. 13, 231-259 (Pubitemid 28034526)
12. Körner, A., Blüher, S., Kapellen, T., Garten, A., Klammt, J., Kratzsch, J., and Kiess, W. (2005) Obesity in childhood and adolescence: a review in the interface between adipocyte physiology and clinical challenges. Hormones 4, 189-199
13. Takeda, S., Elefteriou, F., Levasseur, R., Liu, X., Zhao, L., Parker, K. L., Armstrong, D., Ducy, P., and Karsenty, G. (2002) Leptin regulates bone formation via the sympathetic nervous system. Cell 111, 305-317 (Pubitemid 35345151)
14. Holst, J. J. (2007) The physiology of glucagon-like peptide 1. Physiol. Rev. 87, 1409-1439
15. Lovshin, J. A., and Drucker, D. J. (2009) Incretin-based therapies for type 2 diabetes mellitus. Nat. Rev. Endocrinol. 5, 262-269
16. Hayes, M. R., Kanoski, S. E., Alhadeff, A. L., and Grill, H. J. (2011) Comparative effects of the long-acting GLP-1 receptor ligands, liraglutide and exendin-4, on food intake and body weight suppression in rats. Obesity 19, 1342-1349
17. Drucker, D. J. (2006) The biology of incretin hormones. Cell Metab. 3, 153-165
18. Huang, Y., Wilkinson, G. F., and Willars, G. B. (2010) Role of the signal peptide in the synthesis and processing of the glucagon-like peptide-1 receptor. Br. J. Pharmacol. 159, 237-251
19. Li, Y., Tweedie, D., Mattson, M. P., Holloway, H. W., and Greig, N. H. (2010) Enhancing the GLP-1 receptor signaling pathway leads to proliferation and neuroprotection in human neuroblastoma cells. J Neurochem. 113, 1621-1631
20. Montrose-Rafizadeh, C., Yang, H., Wang, Y., Roth, J., Montrose, M. H., and Adams, L. G. (1997) Novel signal transduction and peptide specificity of glucagon-like peptide receptor in 3T3-L1 adipocytes. 37 J. Cell. Physiol. 172, 275-283 (Pubitemid 27376193)
21. Quoyer, J., Longuet, C., Broca, C., Linck, N., Costes, S., Varin, E., Bockaert, J., Bertrand, G., and Dalle, S. (2010) GLP-1 mediates antiapoptotic effect by phosphorylating Bad through a β-arrestin 1-mediated ERK1/2 activation in pancreatic β-cells. J. Biol. Chem. 285, 1989-2002
22. Zander, M., Madsbad, S., Madsen, J. L., and Holst, J. J. (2002) Effect of 6-week course of glucagon-like peptide 1 on glycaemic control, insulin sensitivity, and beta-cell function in type 2 diabetes: a parallel-group study. Lancet 359, 824-830 (Pubitemid 34233752)
23. Drucker, D. J., Dritselis, A., and Kirkpatrick, P. (2010) Liraglutide. Nat. Rev. Drug Discov. 9, 267-268
24. Knudsen, L. B., Nielsen, P. F., Huusfeldt, P. O., Johansen, N. L., Madsen, K., Pedersen, F. Z., Thøgersen, H., Wilken, M., and Agersø, H. (2000) Potent derivatives of glucagon-like peptide-1 with pharmacokinetic properties suitable for once daily administration. J. Med. Chem. 43, 1664-1669 (Pubitemid 30304999)
25. Rask, E., Olsson, T., Söderberg, S., Johnson, O., Seckl, J., Holst, J. J., and Ahrén, B. (2001) Impaired incretin response after a mixed meal is associated with insulin resistance in nondiabetic men. Diabetes Care 24, 1640-1645 (Pubitemid 33716463)
26. Verdich, C., Toubro, S., Buemann, B., Lysgård Madsen, J., Juul Holst, J., and Astrup, A. (2001) The role of postprandial releases of insulin and incretin hormones in meal-induced satiety-effect of obesity and weight reduction. Int. J. Obes. Relat. Metab. Disord. 25, 1206-1214 (Pubitemid 32721544)
27. Buteau, J. (2008) GLP-1 receptor signaling: effects on pancreatic beta-cell proliferation and survival. Diabetes Metab. 34, Suppl. 2, S73-S77
28. Meissburger, B., Ukropec, J., Roeder, E., Beaton, N., Geiger, M., Teupser, D., Civan, B., Langhans, W., Nawroth, P. P., Gasperikova, D., Rudofsky, G., and Wolfrum, C. (2011) EMBO Mol. Med. 3, 637-651
29. Egan, J. M., Montrose-Rafizadeh, C., Wang, Y., Bernier, M., and Roth, J. (1994) Glucagon-like peptide-1(7-36) amide (GLP-1) enhances insulin-stimulated glucose metabolism in 3T3-L1 adipocytes: one of several potential extrapancreatic sites of GLP-1 action. Endocrinology 135, 2070-2075 (Pubitemid 24363904)
30. Lo, Y. F., Cheung, Y. C., Hsueh, S., and Ho, K. C. (2009) Feasibility of sentinel lymph node biopsy in multifocal/multicentric breast cancer. Chang Gung Med. J. 32, 51-58
31. Tong, J., Tschöp, M. H., Aulinger, B. A., Davis, H. W., Yang, Q., Liu, J., Gaylinn, B. D., Thorner, M. O., D'Alessio, D., and Tso, P. (2010) The intestinal lymph fistula model-a novel approach to study ghrelin secretion. Am. J. Physiol. Gastrointest. Liver Physiol. 298, G474-G480
32. von der Weid, P. Y., and Rainey, K. J. (2010) Review article: lymphatic system and associated adipose tissue in the development of inflammatory bowel disease. Aliment Pharmacol. Ther. 32, 697-711
33. Harvey, N. L., Srinivasan, R. S., Dillard, M. E., Johnson, N. C., Witte, M. H., Boyd, K., Sleeman, M. W., and Oliver, G. (2005) Lymphatic vascular defects promoted by Prox1 haploinsufficiency cause adult-onset obesity. Nat. Genet. 37, 1072-1081 (Pubitemid 41486659)
34. Bregenholt, S., Møldrup, A., Blume, N., Karlsen, A. E., Nissen Friedrichsen, B., Tornhave, D., Knudsen, L. B., and Petersen, J. S. (2005) The longacting glucagon-like peptide-1 analogue, liraglutide, inhibits β-cell apoptosis in vitro. Biochem. Biophys. Res. Commun. 330, 577-584 (Pubitemid 40417684)
35. Mari, A., Degn, K., Brock, B., Rungby, J., Ferrannini, E., and Schmitz, O. (2007) Effects of the long-acting human glucagon-like peptide-1 analog liraglutide on beta-cell function in normal living conditions. Diabetes Care 30, 2032-2033 (Pubitemid 47219415)
36. Noyan-Ashraf, M. H., Momen, M. A., Ban, K., Sadi, A. M., Zhou, Y. Q., Riazi, A. M., Baggio, L. L., Henkelman, R. M., Husain, M., and Drucker, D. J. (2009) GLP-1R agonist liraglutide activates cytoprotective pathways and improves outcomes after experimental myocardial infarction in mice. Diabetes 58, 975-983
37. Dubuisson, O., Dhurandhar, E. J., Krishnapuram, R., Kirk-Ballard, H., Gupta, A. K., Hegde, V., Floyd, E., Gimble, J. M., and Dhurandhar, N. V. (2011) PPARgamma-independent increase in glucose uptake and adiponectin abundance in fat cells. Endocrinology, 152, 3649-3660
38. Lee, N. K., and Karsenty, G. (2008) Reciprocal regulation of bone and energy metabolism. Trends Endocrinol. Metab. 19, 161-166 (Pubitemid 351847838)
39. Berg, A. H., and Scherer, P. E. (2005) Adipose tissue, inflammation, and cardiovascular disease. Circ. Res. 96, 939-949 (Pubitemid 40712793)
40. Egan, J. M., Bulotta, A., Hui, H., and Perfetti, R. (2003) GLP-1 receptor agonists are growth and differentiation factors for pancreatic islet beta cells. Diabetes Metab. Res. Rev. 19, 115-123 (Pubitemid 36417195)
41. Sanz, C., Vázquez, P., Blázquez, C., Barrio, P. A., Alvarez Mdel, M., and Blázquez, E. (2010) Signaling and biological effects of glucagon-like peptide 1 on the differentiation of mesenchymal stem cells from human bone marrow. Am. J. Physiol. Endocrinol. Metab. 298, E634-643
42. Hansotia, T., Maida, A., Flock, G., Yamada, Y., Tsukiyama, K., Seino, Y., and Drucker, D. J. (2007) Extrapancreatic incretin receptors modulate glucose homeostasis, body weight, and energy expenditure. J. Clin. Invest. 117, 143-152 (Pubitemid 46048461)
43. Thorens, B. (1992) Expression cloning of the pancreatic beta cell receptor for the gluco-incretin hormone glucagon-like peptide 1. Proc. Natl. Acad. Sci. U.S.A. 89, 8641-8645
44. Bost, F., Aouadi, M., Caron, L., and Binétruy, B. (2005) The role of MAPKs in adipocyte differentiation and obesity. Biochimie 87, 51-56 (Pubitemid 40298765)
45. Clemens, M. J., Trayner, I., and Menaya, J. (1992) The role of protein kinase C isoenzymes in the regulation of cell proliferation and differentiation. J. Cell Sci. 103, 881-887 (Pubitemid 23042231)
46. Lacasa, D., Agli, B., and Giudicelli, Y. (1995) Zeta PKC in rat preadipocytes: modulation by insulin and serum mitogenic factors and possible role in adipogenesis. Biochem. Biophys. Res. Commun. 217, 123-130
47. Davidson, L. A., Brown, R. E., Chang, W. C., Morris, J. S., Wang, N., Carroll, R. J., Turner, N. D., Lupton, J. R., and Chapkin, R. S. (2000) Morphodensitometric analysis of protein kinase C β(II) expression in rat colon: modulation by diet and relation to in situ cell proliferation and apoptosis. Carcinogenesis 21, 1513-1519 (Pubitemid 30608218)
48. Baudry, A., Yang, Z. Z., and Hemmings, B. A. (2006) PKBα is required for adipose differentiation of mouse embryonic fibroblasts. J. Cell Sci. 119, 889-897
49. Kim, J. E., and Chen, J. (2004) Regulation of peroxisome proliferator-activated receptor-γ activity by mammalian target of rapamycin and amino acids in adipogenesis. Diabetes 53, 2748-2756 (Pubitemid 39425899)
50. Kortum, R. L., Costanzo, D. L., Haferbier, J., Schreiner, S. J., Razidlo, G. L., Wu, M. H., Volle, D. J., Mori, T., Sakaue, H., Chaika, N. V., Chaika, O. V., and Lewis, R. E. (2005) The molecular scaffold kinase suppressor of Ras 1 (KSR1) regulates adipogenesis. Mol. Cell. Biol. 25, 7592-7604 (Pubitemid 41170121)
51. Friedrichsen, B. N., Neubauer, N., Lee, Y. C., Gram, V. K., Blume, N., Petersen, J. S., Nielsen, J. H., and Møldrup, A. (2006) Stimulation of pancreatic β-cell replication by incretins involves transcriptional induction of cyclin D1 via multiple signaling pathways. J. Endocrinol. 188, 481-492
52. Zhou, Y., Wang, D., Li, F., Shi, J., and Song, J. (2006) Different roles of protein kinase C-βI and -δ in the regulation of adipocyte differentiation. Int. J. Biochem. Cell Biol. 38, 2151-2163 (Pubitemid 44397623)